409A valuation

409A Valuation and Fundraising Valuation

A 409A valuation and a fundraising valuation serve different purposes. US startups often need 409A context for common stock and options, while investors negotiate preferred-stock economics. The 409A sets a defensible fair market value for tax and compensation purposes. The fundraising number is a negotiated price for preferred stock with rights and protections that common stock does not have. Confusing the two or treating them as interchangeable can create tax, legal, and dilution issues later.

Get your valuation range in 2 minutes Review methodology

Why the numbers can differ

409A work generally supports common stock fair market value using methods acceptable to the IRS and option plan administrators. Fundraising valuation reflects investor terms, preferred economics, growth expectations, and negotiation context. The same company can have a $8M 409A and a $12M pre-money fundraising valuation at the same moment because the two processes optimize for different audiences and risk profiles. Option grants priced at the 409A number must be defended as arm's-length; investor preferred economics are set through negotiation.

Common stock versus preferred stock economics and the different risk/return profiles each security carries.
Employee option pricing context that must stay compliant with tax rules even while fundraising negotiations move the preferred price.
Fundraising expectations and investor rights that are layered on top of the common stock value determined by 409A.

When founders should pay attention

Startups usually revisit 409A context around option grants, financing events, material business changes, or equity compensation planning. A material financing, new product launch, or significant customer win can change the 409A number and trigger a new valuation. Ignoring the interaction between 409A and fundraising can lead to option repricing issues, tax complications for employees, or investor questions about why the numbers appear inconsistent.

Issuing employee stock options or refreshing option pools at the current 409A fair market value.
Closing a priced financing round that changes the company's stage and risk profile for the next 409A.
Material changes in company performance, market conditions, or competitive landscape that affect both 409A and fundraising numbers.

How Evaldam helps

Evaldam does not replace qualified 409A, tax, or legal providers. It helps founders understand fundraising valuation context before those workflows intersect. You can generate a defensible fundraising range with full methodology and assumptions documented, then share that context with your 409A provider, counsel, or board. This preparation reduces last-minute surprises when the 409A and fundraising processes run in parallel.

Fundraising valuation range with documented assumptions that you can provide to 409A providers for context.
Assumption documentation and sensitivity analysis that shows how the range responds to different inputs.
Report context for advisors and counsel that makes the connection between fundraising goals and common stock considerations clearer.

Founder questions

Is Evaldam a 409A provider?

No. Evaldam is a startup valuation and reporting workflow for fundraising preparation. Formal 409A work should be handled by qualified providers who are responsible for the tax and compliance aspects of common stock fair market value.

Why do founders compare 409A and fundraising valuation?

They both mention company value, but they are built for different securities, audiences, and decisions. Treating them as interchangeable can create confusion with employees, the board, or future investors. Understanding the differences helps you communicate clearly and avoid tax or legal surprises.

Can a fundraising valuation affect future 409A numbers?

Yes. A priced round at a new valuation often becomes a significant input for the next 409A. Large gaps between the two numbers can trigger questions from the 409A provider or the IRS, so founders should document the reasoning behind both.

What should founders do if the 409A comes in much lower than the fundraising valuation?

Work with qualified 409A counsel and your board to understand the drivers. In some cases a new 409A is required after the round; in others you may need to explain the difference to employees receiving options. Using Evaldam to model both the fundraising and common stock implications in advance reduces the chance of surprises.

Evaldam AI

Turn the topic into a company-specific range

Use the free valuation preview when you need a starting range, then create the full report when you need assumptions, comparables, scenarios, and investor-ready output.

Generate my valuation range

409A Valuation and Fundraising Valuation

Why the numbers can differ

Common stock versus preferred stock economics and the different risk/return profiles each security carries.

Employee option pricing context that must stay compliant with tax rules even while fundraising negotiations move the preferred price.

Fundraising expectations and investor rights that are layered on top of the common stock value determined by 409A.

When founders should pay attention

Issuing employee stock options or refreshing option pools at the current 409A fair market value.

Closing a priced financing round that changes the company's stage and risk profile for the next 409A.

Material changes in company performance, market conditions, or competitive landscape that affect both 409A and fundraising numbers.

How Evaldam helps

Fundraising valuation range with documented assumptions that you can provide to 409A providers for context.

Assumption documentation and sensitivity analysis that shows how the range responds to different inputs.

Report context for advisors and counsel that makes the connection between fundraising goals and common stock considerations clearer.